Written by
Bilal H
Bilal H Liv Hospital Content Team
Medically reviewed by

Related Doctors

Assoc. Prof. MD. Evrim Duman Liv Hospital Ulus Assoc. Prof. MD. Evrim Duman Radiation Oncology Asst. Prof. MD. Meltem Topalgökçeli Selam Liv Hospital Ulus Asst. Prof. MD. Meltem Topalgökçeli Selam Medical Oncology Prof. MD. Duygu Derin Liv Hospital Ulus Prof. MD. Duygu Derin Medical Oncology Prof. MD. Emre Merdan Fayda Liv Hospital Ulus Prof. MD. Emre Merdan Fayda Radiation Oncology Prof. MD. Meral Günaldı Liv Hospital Ulus Prof. MD. Meral Günaldı Medical Oncology Assoc. Prof. MD. Murat Ayhan Liv Hospital Vadistanbul Assoc. Prof. MD. Murat Ayhan Medical Oncology Prof. MD.  Itır Şirinoğlu Demiriz Liv Hospital Vadistanbul Prof. MD. Itır Şirinoğlu Demiriz Hematology Prof. MD. Tülin Tıraje Celkan Liv Hospital Vadistanbul Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology Assoc. Prof. MD. Erkan Kayıkçıoğlu Liv Hospital Bahçeşehir Assoc. Prof. MD. Erkan Kayıkçıoğlu Medical Oncology Assoc. Prof. MD. Mine Dağgez Liv Hospital Bahçeşehir Assoc. Prof. MD. Mine Dağgez Gynecological Oncology Assoc. Prof. MD. Ozan Balakan Liv Hospital Bahçeşehir Assoc. Prof. MD. Ozan Balakan Medical Oncology MD. Taylan Bükülmez Liv Hospital Bahçeşehir MD. Taylan Bükülmez Radiation Oncology Op. MD. Alp Koray Kinter Liv Hospital Bahçeşehir Op. MD. Alp Koray Kinter Gynecological Oncology Prof. MD. Nuri Faruk Aykan Liv Hospital Bahçeşehir Prof. MD. Nuri Faruk Aykan Medical Oncology Spec. MD. Özlem Doğan Liv Hospital Bahçeşehir Spec. MD. Özlem Doğan Medical Oncology Assoc. Prof. MD. Emir Çelik Liv Hospital Topkapı Assoc. Prof. MD. Emir Çelik Medical Oncology Assoc. Prof. MD. Muhammed Mustafa Atcı Liv Hospital Topkapı Assoc. Prof. MD. Muhammed Mustafa Atcı Medical Oncology Prof. MD. İrfan Çiçin Liv Hospital Topkapı Prof. MD. İrfan Çiçin Medical Oncology Assoc. Prof. MD.  Ramazan Öcal Liv Hospital Ankara Assoc. Prof. MD. Ramazan Öcal Hematology Assoc. Prof. MD. Nazlı Topfedaisi Özkan Liv Hospital Ankara Assoc. Prof. MD. Nazlı Topfedaisi Özkan Gynecological Oncology Prof. MD. Fikret Arpacı Liv Hospital Ankara Prof. MD. Fikret Arpacı Medical Oncology Prof. MD. Gökhan Erdem Liv Hospital Ankara Prof. MD. Gökhan Erdem Medical Oncology Prof. MD. Meral Beksaç Liv Hospital Ankara Prof. MD. Meral Beksaç Hematology Prof. MD. Oral Nevruz Liv Hospital Ankara Prof. MD. Oral Nevruz Hematology Prof. MD. Saadettin Kılıçkap Liv Hospital Ankara Prof. MD. Saadettin Kılıçkap Medical Oncology Prof. MD. Sadık Muallaoğlu Liv Hospital Ankara Prof. MD. Sadık Muallaoğlu Medical Oncology Spec. MD. Ender Kalacı Liv Hospital Ankara Spec. MD. Ender Kalacı Medical Oncology Assoc. Prof. MD. Fadime Ersoy Dursun Liv Hospital Gaziantep Assoc. Prof. MD. Fadime Ersoy Dursun Hematology Prof. MD. Fatih Teker Liv Hospital Gaziantep Prof. MD. Fatih Teker Medical Oncology Spec. MD. ELXAN MEMMEDOV Liv Bona Dea Hospital Bakü Spec. MD. ELXAN MEMMEDOV Medical Oncology Spec. MD. Ceyda Aslan Spec. MD. Ceyda Aslan Hematology Spec. MD. Elkhan Mammadov Spec. MD. Elkhan Mammadov Medical Oncology Spec. MD. Elmir İsrafilov Spec. MD. Elmir İsrafilov Hematology Spec. MD. Minure Abışova Eliyeva Spec. MD. Minure Abışova Eliyeva Hematology Spec. MD. Natavan Azizova Spec. MD. Natavan Azizova Medical Oncology Prof. MD. Mehmet Hilmi Doğu Liv Hospital Ulus + Liv Hospital Bahçeşehir Prof. MD. Mehmet Hilmi Doğu Hematology
...
Views
Read Time
...
views
Read Time

Knowing the survival rate for lymphoma is key for those facing a diagnosis. At Liv Hospital, we focus on the latest treatments. We aim to improve both life expectancy and quality of life.

The prognosis for lymph node cancer changes a lot. It depends on the lymphoma type and the patient’s health. For non-Hodgkin’s lymphoma (NHL), the 5-year survival rate is about 74%. Early detection is key, but survival rates drop at later stages.

We’re all about top-notch healthcare and support for international patients. Our team offers clear medical advice and a personal touch.

Key Takeaways

  • Survival rates for lymphoma vary based on the type and stage at diagnosis.
  • Non-Hodgkin’s lymphoma has an overall 5-year survival rate of approximately 74%.
  • Early detection significantly improves survival rates.
  • Individual patient factors play a critical role in determining prognosis.
  • Liv Hospital provides complete care and support for international patients.

Understanding Lymph Node Cancer and Its Stages

image 749 LIV Hospital
Stage 3 Lymph Node Cancer Survival Rate: Key Facts About Lymphoma Prognosis 2

Learning about lymphoma and its effects on the lymphatic system is key for those with lymph node cancer. Lymphoma, a cancer that starts in the lymphatic system, can weaken the body’s immune defense.

What Is Lymphoma and How It Affects the Lymphatic System

Lymphoma is a cancer that comes from lymphocytes, a type of white blood cell important for the immune system. The lymphatic system, including lymph nodes, spleen, and lymphoid tissues, helps fight infections. When lymphoma develops, it can harm this defense, causing health problems.

Lymphoma is mainly divided into two types: Hodgkin’s lymphoma and non-Hodgkin’s lymphoma (NHL). Both types affect the lymphatic system but differ in characteristics and outlook. Non-Hodgkin’s lymphoma is more common and has many subtypes, each with its own treatment.

The Staging System for Lymph Node Cancer

The staging system for lymph node cancer is vital for knowing how far the disease has spread and planning treatment. The Ann Arbor Staging System is commonly used. It divides lymphoma into four stages based on lymph node involvement and symptoms.

  • Stage I: The lymphoma is in one lymph node group.
  • Stage II: The lymphoma is in two or more lymph node groups on the same side of the diaphragm.
  • Stage III: The lymphoma is in lymph node groups on both sides of the diaphragm.
  • Stage IV: The lymphoma has spread to other organs.

Characteristics of Stage 3 Lymphoma

Stage 3 lymphoma means the cancer has spread to lymph nodes on both sides of the diaphragm. This is a more advanced stage. The lymphoma may affect many lymph node groups and sometimes the spleen.

CharacteristicsDescription
Lymph Node InvolvementLymph nodes on both sides of the diaphragm are affected.
Spleen InvolvementThe spleen may be involved in some cases.
Systemic SymptomsPatients may have symptoms like fever, night sweats, and weight loss.

Research shows that lymphoma in the bone marrow or advanced cases can shorten life expectancy. The outlook for stage 3 lymphoma depends on several factors. These include the lymphoma subtype, the patient’s age, and overall health.

Being diagnosed with stage 3 lymphoma can be tough. But, thanks to medical progress, many patients manage their condition well. The survival rate for B cell non-Hodgkin’s lymphoma varies by subtype. But, B cell lymphoma survival rates generally follow overall NHL statistics.

Stage 3 Lymph Node Cancer Survival Rate

A detailed medical illustration depicting the stage 3 lymph node cancer survival rate. In the foreground, a stylized lymph node structure showcases the progression of the malignancy. The middle ground features a line graph presenting survival statistics, conveying the prognosis for this stage of lymphoma. The background is a softly blurred medical environment, with subtle anatomical references to provide context. The lighting is clean and clinical, emphasizing the informative nature of the image. The overall mood is one of objective, factual presentation, guiding the viewer through the key data points related to stage 3 lymph node cancer survival.
Stage 3 Lymph Node Cancer Survival Rate: Key Facts About Lymphoma Prognosis 3

Knowing the survival rate for stage 3 lymph node cancer is key for both patients and doctors. The survival rate for stage 3 lymph node cancer is important. It helps understand the prognosis and guides treatment choices.

Current Statistical Data on Stage 3 Lymphoma Survival

Recent studies show that survival rates for lymphoma, including stage 3, have greatly improved. Thanks to new treatments, many stage 3 lymphoma patients reach remission.

For non-Hodgkin’s lymphoma (NHL), the 5-year survival rate is about 74%. This shows the progress in treating this disease. But, survival rates can change based on many factors. These include the type of lymphoma, age, overall health, and how well the cancer responds to treatment.

5-Year Survival Rate Explanation

The 5-year survival rate is a key statistic for cancer patients. It shows the percentage of patients alive five years after diagnosis. For stage 3 lymph node cancer, this rate gives a general idea of survival expectations.

“The 5-year survival rate for cancer patients is a critical metric that helps in understanding the effectiveness of treatments and the prognosis.”

Interpreting Survival Statistics for Patients

Survival statistics are based on large groups and may not predict an individual’s outcome. Many factors affect survival rates. These include the patient’s overall health, the cancer’s characteristics, and how it responds to treatment.

Factors Influencing Survival RateDescriptionImpact on Survival
AgeThe patient’s age at diagnosisGenerally, younger patients have better survival rates
Cancer TypeThe specific type of lymphomaSome types have better prognosis than others
Overall HealthThe patient’s health status beyond the cancer diagnosisPatients with fewer comorbidities tend to have better survival rates
Treatment ResponseHow well the cancer responds to treatmentA positive response is associated with better survival

While statistics are helpful, each patient’s journey is unique. It’s important for patients to talk about their prognosis and treatment options with their healthcare provider.

Non-Hodgkin’s Lymphoma vs. Hodgkin’s Lymphoma Prognosis

To understand lymphoma prognosis, we must know the difference between Non-Hodgkin’s and Hodgkin’s Lymphoma. Each type has its own survival rate. It’s key to grasp their unique traits.

Differences in Survival Rates Between Lymphoma Types

Survival rates for Non-Hodgkin’s and Hodgkin’s Lymphoma vary. This is due to disease aggressiveness and treatment response. Non-Hodgkin’s Lymphoma is more common, with many subtypes each having its own survival outlook.

Hodgkin’s Lymphoma is rarer but often has a better prognosis, mainly if caught early. Survival rates also depend on treatment progress and individual patient factors.

Non-Hodgkin’s Lymphoma 5-Year Survival Rate of 74%

The 5-year survival rate for Non-Hodgkin’s Lymphoma is about 74%, thanks to better treatments. This rate has grown over time.

But, survival rates can change a lot. This depends on the Non-Hodgkin’s Lymphoma subtype, diagnosis stage, and patient health.

Hodgkin’s Lymphoma Survival Statistics

Hodgkin’s Lymphoma has a high cure rate, mainly if caught and treated early. Its 5-year survival rate is generally higher than Non-Hodgkin’s, often between 85% to 90% or more.

Modern treatments have greatly improved lymphoma patient outcomes. We’re seeing more effective treatments and better survival rates. This leads to a better life quality for patients.

B Cell Lymphoma Survival Rates and Prognosis

Knowing the survival rates and prognosis for B cell lymphoma is key for those diagnosed. B cell lymphoma is a type of non-Hodgkin’s lymphoma. Its outlook changes based on the specific type.

Research shows that B cell lymphoma survival rates are similar to those of non-Hodgkin’s lymphoma overall. The survival rate for stage 3 lymph node cancer is a big concern for those with advanced disease. It’s vital to look at the lymphoma’s specific traits when considering survival rates by stage.

The survival rate for advanced lymph node cancer can be affected by many things. This includes how well treatment works and the patient’s overall health. Understanding these factors helps both patients and doctors deal with lymphoma’s complexities.

## FAQ

### Q: What is the stage 3 lymph node cancer survival rate?

A: The survival rate for stage 3 lymph node cancer changes based on the lymphoma type. It also depends on the patient’s health. We share current data to help patients understand their chances.

### Q: How does the type of lymphoma affect the survival rate?

A: Non-Hodgkin’s and Hodgkin’s lymphomas have different survival rates. Knowing these differences is key for patients to understand their prognosis.

### Q: What is the 5-year survival rate for stage 3 lymphoma?

A: The 5-year survival rate for stage 3 lymphoma varies by lymphoma type. Non-Hodgkin’s lymphoma has a 74% rate. Hodgkin’s lymphoma has a higher rate.

### Q: How is the staging system for lymph node cancer determined?

A: The staging system for lymph node cancer is based on how far the cancer has spread. Stage 3 means the cancer is in lymph nodes on both sides of the diaphragm.

### Q: What are the characteristics of stage 3 lymphoma?

A: Stage 3 lymphoma means the cancer has spread to lymph nodes on both sides of the diaphragm. This indicates a more advanced stage.

### Q: How do survival statistics for lymphoma patients get interpreted?

A: Survival statistics for lymphoma patients depend on the lymphoma type, stage, and individual factors. Understanding these helps patients make informed treatment choices.

### Q: What is the prognosis for b cell lymphoma?

A: The prognosis for b cell lymphoma, a non-Hodgkin’s lymphoma subtype, varies. It depends on the specific subtype and stage at diagnosis.

### Q: How does the stage 3 lymph node cancer survival rate compare between non-Hodgkin’s lymphoma and Hodgkin’s lymphoma?

A: The survival rate for stage 3 lymph node cancer is different for non-Hodgkin’s and Hodgkin’s lymphomas. Hodgkin’s lymphoma generally has a better prognosis.

### Q: What is the advanced stage lymph node cancer survival rate?

A: The survival rate for advanced stage lymph node cancer varies by lymphoma type and patient factors. We provide current data to help patients understand their prognosis.

References

  1. American Cancer Society (Cancer.org): Factors Affecting Prognosis for Non-Hodgkin Lymphoma
  2. Breast Cancer Research Foundation (BCRF): About Breast Cancer: Breast Cancer Stages
  3. PubMed (NCBI): Prognostic Factors in Follicular Lymphoma

i

Medical Disclaimer

The content on this page is for informational purposes only and is not a substitute for professional medical advice, diagnosis or treatment. Always consult a qualified healthcare provider regarding any medical conditions.

Get a Free Quote

Response within 2 hours during business hours

Clinics/branches
GDPR

Related Doctors

Assoc. Prof. MD. Evrim Duman Liv Hospital Ulus Assoc. Prof. MD. Evrim Duman Radiation Oncology Asst. Prof. MD. Meltem Topalgökçeli Selam Liv Hospital Ulus Asst. Prof. MD. Meltem Topalgökçeli Selam Medical Oncology Prof. MD. Duygu Derin Liv Hospital Ulus Prof. MD. Duygu Derin Medical Oncology Prof. MD. Emre Merdan Fayda Liv Hospital Ulus Prof. MD. Emre Merdan Fayda Radiation Oncology Prof. MD. Meral Günaldı Liv Hospital Ulus Prof. MD. Meral Günaldı Medical Oncology Assoc. Prof. MD. Murat Ayhan Liv Hospital Vadistanbul Assoc. Prof. MD. Murat Ayhan Medical Oncology Prof. MD.  Itır Şirinoğlu Demiriz Liv Hospital Vadistanbul Prof. MD. Itır Şirinoğlu Demiriz Hematology Prof. MD. Tülin Tıraje Celkan Liv Hospital Vadistanbul Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology Assoc. Prof. MD. Erkan Kayıkçıoğlu Liv Hospital Bahçeşehir Assoc. Prof. MD. Erkan Kayıkçıoğlu Medical Oncology Assoc. Prof. MD. Mine Dağgez Liv Hospital Bahçeşehir Assoc. Prof. MD. Mine Dağgez Gynecological Oncology Assoc. Prof. MD. Ozan Balakan Liv Hospital Bahçeşehir Assoc. Prof. MD. Ozan Balakan Medical Oncology MD. Taylan Bükülmez Liv Hospital Bahçeşehir MD. Taylan Bükülmez Radiation Oncology Op. MD. Alp Koray Kinter Liv Hospital Bahçeşehir Op. MD. Alp Koray Kinter Gynecological Oncology Prof. MD. Nuri Faruk Aykan Liv Hospital Bahçeşehir Prof. MD. Nuri Faruk Aykan Medical Oncology Spec. MD. Özlem Doğan Liv Hospital Bahçeşehir Spec. MD. Özlem Doğan Medical Oncology Assoc. Prof. MD. Emir Çelik Liv Hospital Topkapı Assoc. Prof. MD. Emir Çelik Medical Oncology Assoc. Prof. MD. Muhammed Mustafa Atcı Liv Hospital Topkapı Assoc. Prof. MD. Muhammed Mustafa Atcı Medical Oncology Prof. MD. İrfan Çiçin Liv Hospital Topkapı Prof. MD. İrfan Çiçin Medical Oncology Assoc. Prof. MD.  Ramazan Öcal Liv Hospital Ankara Assoc. Prof. MD. Ramazan Öcal Hematology Assoc. Prof. MD. Nazlı Topfedaisi Özkan Liv Hospital Ankara Assoc. Prof. MD. Nazlı Topfedaisi Özkan Gynecological Oncology Prof. MD. Fikret Arpacı Liv Hospital Ankara Prof. MD. Fikret Arpacı Medical Oncology Prof. MD. Gökhan Erdem Liv Hospital Ankara Prof. MD. Gökhan Erdem Medical Oncology Prof. MD. Meral Beksaç Liv Hospital Ankara Prof. MD. Meral Beksaç Hematology Prof. MD. Oral Nevruz Liv Hospital Ankara Prof. MD. Oral Nevruz Hematology Prof. MD. Saadettin Kılıçkap Liv Hospital Ankara Prof. MD. Saadettin Kılıçkap Medical Oncology Prof. MD. Sadık Muallaoğlu Liv Hospital Ankara Prof. MD. Sadık Muallaoğlu Medical Oncology Spec. MD. Ender Kalacı Liv Hospital Ankara Spec. MD. Ender Kalacı Medical Oncology Assoc. Prof. MD. Fadime Ersoy Dursun Liv Hospital Gaziantep Assoc. Prof. MD. Fadime Ersoy Dursun Hematology Prof. MD. Fatih Teker Liv Hospital Gaziantep Prof. MD. Fatih Teker Medical Oncology Spec. MD. ELXAN MEMMEDOV Liv Bona Dea Hospital Bakü Spec. MD. ELXAN MEMMEDOV Medical Oncology Spec. MD. Ceyda Aslan Spec. MD. Ceyda Aslan Hematology Spec. MD. Elkhan Mammadov Spec. MD. Elkhan Mammadov Medical Oncology Spec. MD. Elmir İsrafilov Spec. MD. Elmir İsrafilov Hematology Spec. MD. Minure Abışova Eliyeva Spec. MD. Minure Abışova Eliyeva Hematology Spec. MD. Natavan Azizova Spec. MD. Natavan Azizova Medical Oncology Prof. MD. Mehmet Hilmi Doğu Liv Hospital Ulus + Liv Hospital Bahçeşehir Prof. MD. Mehmet Hilmi Doğu Hematology
Trusted Worldwide
30
Years of
Experience
30 Years Badge
Health Türkiye Accreditation

Trusted Worldwide

30 Years of Experience

Patient Reviews
Reviews from 9,651
4,9
Was this content helpful?
Your feedback helps us improve.
What did you like?
Share more details about your experience.
You must give consent to continue.

Thank you!

Your feedback has been submitted successfully. Your input is valuable in helping us improve.

Book a Free Certified Online
Doctor Consultation

Clinics/branches
GDPR

We're Here to Help.
Get in Touch

Send us all your questions or requests, and our
expert team will assist you.

Our Doctors

Assoc. Prof. MD. Evrim Duman Radiation Oncology

Assoc. Prof. MD. Evrim Duman

Liv Hospital Ulus
Asst. Prof. MD. Meltem Topalgökçeli Selam Medical Oncology

Asst. Prof. MD. Meltem Topalgökçeli Selam

Liv Hospital Ulus
Prof. MD. Duygu Derin Medical Oncology

Prof. MD. Duygu Derin

Liv Hospital Ulus
Prof. MD. Emre Merdan Fayda Radiation Oncology

Prof. MD. Emre Merdan Fayda

Liv Hospital Ulus
Prof. MD. Mehmet Hilmi Doğu Hematology

Prof. MD. Mehmet Hilmi Doğu

Liv Hospital Ulus
Liv Hospital Bahçeşehir
Prof. MD. Meral Günaldı Medical Oncology

Prof. MD. Meral Günaldı

Liv Hospital Ulus
Assoc. Prof. MD. Murat Ayhan Medical Oncology

Assoc. Prof. MD. Murat Ayhan

Liv Hospital Vadistanbul
Prof. MD.  Itır Şirinoğlu Demiriz Hematology

Prof. MD. Itır Şirinoğlu Demiriz

Liv Hospital Vadistanbul
Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology

Prof. MD. Tülin Tıraje Celkan

Liv Hospital Vadistanbul
Assoc. Prof. MD. Erkan Kayıkçıoğlu Medical Oncology

Assoc. Prof. MD. Erkan Kayıkçıoğlu

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Mine Dağgez Gynecological Oncology

Assoc. Prof. MD. Mine Dağgez

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Ozan Balakan Medical Oncology

Assoc. Prof. MD. Ozan Balakan

Liv Hospital Bahçeşehir
MD. Taylan Bükülmez Radiation Oncology

MD. Taylan Bükülmez

Liv Hospital Bahçeşehir
Op. MD. Alp Koray Kinter Gynecological Oncology

Op. MD. Alp Koray Kinter

Liv Hospital Bahçeşehir
Prof. MD. Nuri Faruk Aykan Medical Oncology

Prof. MD. Nuri Faruk Aykan

Liv Hospital Bahçeşehir
Spec. MD. Özlem Doğan Medical Oncology

Spec. MD. Özlem Doğan

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Emir Çelik Medical Oncology

Assoc. Prof. MD. Emir Çelik

Liv Hospital Topkapı
Assoc. Prof. MD. Muhammed Mustafa Atcı Medical Oncology

Assoc. Prof. MD. Muhammed Mustafa Atcı

Liv Hospital Topkapı
Prof. MD. İrfan Çiçin Medical Oncology

Prof. MD. İrfan Çiçin

Liv Hospital Topkapı
Assoc. Prof. MD.  Ramazan Öcal Hematology

Assoc. Prof. MD. Ramazan Öcal

Liv Hospital Ankara
Assoc. Prof. MD. Nazlı Topfedaisi Özkan Gynecological Oncology

Assoc. Prof. MD. Nazlı Topfedaisi Özkan

Liv Hospital Ankara
Prof. MD. Fikret Arpacı Medical Oncology

Prof. MD. Fikret Arpacı

Liv Hospital Ankara
Prof. MD. Gökhan Erdem Medical Oncology

Prof. MD. Gökhan Erdem

Liv Hospital Ankara
Prof. MD. Meral Beksaç Hematology

Prof. MD. Meral Beksaç

Liv Hospital Ankara
Prof. MD. Oral Nevruz Hematology

Prof. MD. Oral Nevruz

Liv Hospital Ankara
Prof. MD. Saadettin Kılıçkap Medical Oncology

Prof. MD. Saadettin Kılıçkap

Liv Hospital Ankara
Prof. MD. Sadık Muallaoğlu Medical Oncology

Prof. MD. Sadık Muallaoğlu

Liv Hospital Ankara
Spec. MD. Ender Kalacı Medical Oncology

Spec. MD. Ender Kalacı

Liv Hospital Ankara
Assoc. Prof. MD. Fadime Ersoy Dursun Hematology

Assoc. Prof. MD. Fadime Ersoy Dursun

Liv Hospital Gaziantep
Prof. MD. Fatih Teker Medical Oncology

Prof. MD. Fatih Teker

Liv Hospital Gaziantep
Spec. MD. ELXAN MEMMEDOV Medical Oncology

Spec. MD. ELXAN MEMMEDOV

Liv Bona Dea Hospital Bakü
Spec. MD. Ceyda Aslan Hematology

Spec. MD. Ceyda Aslan

Spec. MD. Elkhan Mammadov Medical Oncology

Spec. MD. Elkhan Mammadov

Spec. MD. Elmir İsrafilov Hematology

Spec. MD. Elmir İsrafilov

Spec. MD. Minure Abışova Eliyeva Hematology

Spec. MD. Minure Abışova Eliyeva

Spec. MD. Natavan Azizova Medical Oncology

Spec. MD. Natavan Azizova

Need Help? Chat with our medical team

Let's Talk on WhatsApp

📌

Get instant answers from our medical team. No forms, no waiting — just tap below to start chatting now.

or call us at +90 530 174 26 75